Date: September 23, 2025
Attention: All Providers
Subject: 2025–26 RSV Season and Synagis Prior Authorization for All State Health Service Regions
Effective Date: October 1, 2025
Call to action: Texas Children’s Health Plan (TCHP) would like to let providers know that effective October 1, 2025, the Texas Health and Human Services (HHSC) will open all counties in State Health Service to Palivizumab (Synagis) prophylaxis for 2025-26 Fall/Winter Respiratory Syncytial Virus (RSV) season. Refer to the season schedule for each region's start and end dates.
How this impacts providers: HHSC will accept fee-for-service (FFS) prior authorization requests by fax and as early as September 22, 2025.
Prescribing providers must prescribe Synagis to infants meeting the criteria as described on the American Academy of Pediatrics website.
Drug Name | Strength | NDC |
Synagis | 100 MG/1 ml Vial | 66658023101 |
Synagis | 50 MG/0.5 ml Vial | 66658023001 |
Similar to STAR and STAR KIDS, Synagis for CHIP members will be available through the pharmacy benefit. Prior authorization (PA) criteria will be the same for all members.
- Initial PA Request Required
Providers must submit a new PA request for all members who meet criteria for RSV prophylaxis. Only one initial request is needed per treatment course (up to five doses).
Approvals will be granted for one monthly dose at a time, with a 10-day window for pharmacy adjudication. Providers should retain Synagis vials until administration to avoid missed doses.
- Required Forms for PA Submission
Providers must submit both the Texas Department of Insurance (TDI) Synagis PA Form and the TCHP Standard PA Request Form.
- Forms are available on the Navitus page.
- Texas HHSC has also created the Synagis Standard PA Addendum (HHS Form 1321) to accompany the TDI form.
- No Refill PA Required
Pharmacies are not required to submit refill PA requests for subsequent doses.
Members hospitalized for RSV during the season may be denied further Synagis refills.
Acaria Health Pharmacy and Lumicera Specialty Pharmacy are the preferred options for all providers.
2025-26 Synagis Prior Authorization Schedule:
Updated as of September 11, 2025. Refer to HHSC’s website for the most up-to-date information.
Providers can find their region using theinteractive region map (PDF)and selecting the buttons marked HHS regions and county names.
Table 1: Region Dates
Region | Start Date | End Date |
1 - High Plains | Nov. 15, 2025 | April 17, 2026 |
2 - Northwest Texas | Nov. 15, 2025 | April 17, 2026 |
3 - Metroplex | Nov. 1, 2025 | March 31, 2026 |
4 - Upper East Texas | Nov. 1, 2025 | March 31, 2026 |
5 - Southeast Texas | Oct. 1, 2025 | Feb. 28, 2026 |
6 - Gulf Coast | Oct. 1, 2025 | Feb. 28, 2026 |
7 - Central Texas | Oct. 15, 2025 | March 13, 2026 |
8 - Upper South Texas | Nov. 1, 2025 | March 31, 2025 |
9 - West Texas | Nov. 15, 2025 | April 17, 2026 |
10 - Upper Rio Grande | Nov. 15, 2025 | April 17, 2026 |
11 - Lower South Texas | Oct. 15, 2025 | March 31, 2026 |
Next steps for providers: Refer to the 2025-2026 RSV season schedule for information regarding start and end dates for all regions. Providers should continue to follow American Academy of Pediatrics guidelines when prescribing and should share this communication with their staff.
Resources:
If you have any questions, please email Provider Relations at: providerrelations@texaschildrens.org.
For access to all provider alerts,log into:
www.texaschildrenshealthplan.org/provideralerts.